Successful treatment with nivolumab in a patient with lung adenocarcinoma complicated by pulmonary aspergilloma

Successful treatment with nivolumab in a patient with lung adenocarcinoma complicated by pulmonary aspergilloma

Immune checkpoint inhibitors (ICIs) are the key drugs used in patients with non‐small cell lung cancer (NSCLC). However, anti‐PD‐1 therapy might worsen chronic infection by reactivating the immune response to infectious diseases. Here, we describe a case of successful treatment with nivolumab in a p...

Full description

Bibliographic Details
Main Authors: Naoki Furuya, Koji Kojima, Hideki Marushima, Kazutaka Kakinuma, Akihito Tsunoda, Eriko Koda, Hajime Tsuruoka, Kohei Nishida, Takeo Inoue, Hisashi Saji, Masamichi Mineshita
Format: Article
Language:English
Published: Wiley 2020-11-01
Series:Thoracic Cancer
Subjects:
Anti‐PD‐1 antibody
chronic infection
nivolumab
non‐small cell lung cancer
pulmonary aspergilloma
Online Access:https://doi.org/10.1111/1759-7714.13662

Internet

https://doi.org/10.1111/1759-7714.13662

Similar Items